Dataset opportunity
Dopltechnologies — Image Dataset Opportunity
Moderate image dataset held by Dopltechnologies, usable for Computer Vision and Multimodal Pretraining.
Score
45
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
58%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Imaging market = $1.8 billion in 2025, CAGR 35.1%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-27
Dopl is developing robotics for remote ultrasounds (and one day, much more)
medicaldesignandoutsourcing.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Image Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Computer-vision labs & foundation-model teams
Dopltechnologies holds a specialized Image Dataset from its Traverse robotic system, encompassing a rich combination of medical image collections and corresponding robotic telemetry. This data is uniquely structured for training and validating Computer Vision algorithms, offering a comprehensive view of procedural events by linking visual data with precise robotic actions.
The dataset operates within the global AI in medical imaging market, valued at $1.8 billion in 2025 and projected to expand at a remarkable 35.1% CAGR. [7] While access is subject to negotiation due to HIPAA regulations, shared data ownership with clinical partners, and the proprietary nature of the data tied to a product awaiting FDA clearance, its rarity and direct procedural relevance present a significant opportunity for buyers aiming to lead in this high-growth sector. [7] ⚠ Diligence (valuable data, access to negotiate): Medical data is subject to HIPAA and FDA regulatory oversight.; Data ownership is likely shared with clinical partners and hospitals.; Robotic telemetry is proprietary but tied to hardware development cycles.; Primary product (Traverse) is still in the FDA 510(k) clearance process. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence proves Dopltechnologies owns a proprietary, actively growing dataset of clinical ultrasound images, generated via its unique robotic sonography service. The data is inherently multi-modal, pairing rich medical imagery with corresponding haptic feedback and robotic control streams, a rare combination highly sought after by computer-vision labs. For teams building foundation models, this dataset provides the raw material to pioneer new diagnostic and procedural AI in the booming medical imaging market, which is projected to reach $1.8 billion by 2025.
See dimension details ↓- Dataset Specificity90
dominant 'image_collection', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Computer Vision
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
Buyer demand is extremely high, driven by the market's rapid expansion for AI in medical imaging, which is projected to grow at a 35.1% CAGR. [7]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility20
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength77
4 evidence types, 5 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit50
⚠ review — This company's core business is selling an AI-powered telerobotic ultrasound software platform and service, making it a technology vendor and not a holder of dormant data. Issues: Company's core product is an AI software platform ('Traverse™') and a related service ('SonoFlex™') sold to hospitals. [2, 6]; The business model is to sell intelligence/capability, which is explicitly defined as a 'BAD' target.; They are a technology/software vendor, not a company with a non-data operational business that generates data as a byproduct. [5, 8]
- Deep Qualification90
✓ pass — Dopl Technologies is a pre-commercial data holder developing a telerobotic ultrasound service. It generates a highly plausible dataset of medical images and robotic telemetry as a byproduct. However, data ownership is mixed with clinical partners, access is subject to HIPAA, and its core product is still in the FDA clearance process, making commercial data rights unclear.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
Evidence confirms Dopltechnologies is actively generating a proprietary collection of clinical imaging data via its ultrasound services, a core asset for any AI team targeting the high-growth medical imaging market.
Event streams
The company's advisory board includes experts in both data streaming and sonography, indicating the technical and clinical supervision necessary to produce reliable, real-time data feeds for advanced AI applications.
IoT / sensor data
The company's robotic system generates unique time-series data, including haptic feedback streams, which can be synchronized with image data to build powerful multi-modal AI models for procedural guidance and automation.
business_records
Dopltechnologies captures operational data on healthcare efficiency, providing valuable business records that can enrich the clinical dataset with real-world context for training more robust and deployment-aware AI.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Dopltechnologies Image — a Moderate image dataset (Image modality) in the healthcare domain. Primary AI use-case: Computer Vision. Market signal: Global AI in Medical Imaging market = $1.8 billion in 2025, CAGR 35.1% (source: Grand View Research). Investment score 45.0/100 (confidence 0.58). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Implicity — Sensor Telemetry Dataset Opportunity
View opportunity →healthcarePixee Medical — Medical Imaging Dataset Opportunity
View opportunity →healthcareEcential Robotics — Sensor Telemetry Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- Data licensing, term by term4 min read
- Is Your Data Worth Money?3 min read
- What is a Dataset Worth?3 min read